搜索筛选:
搜索耗时1.2329秒,为你在为你在102,285,761篇论文里面共找到 19 篇相符的论文内容
类      型:
[会议论文] 作者:Jun-Ling Yang,Min Yao,Deng-FuYao, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
[会议论文] 作者:Jun-Ling Yang,Min Yao,Deng-FuYao, 来源:22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) 年份:2013
Objective: To investigate quantitatively the levels of circulating soluble intercellular adhesion molecule-1 (slCAM-1) expression in a range of patients with liver diseases for exploring its diagnosis...
[期刊论文] 作者:Wei Wu,Jun-Ling Yang,Yi-Lang W, 来源:世界肝病学杂志:英文版(电子版) 年份:2016
AIM: To interfere with the activation of nuclear factor-κB(NF-κB) with metformin and explore its effect in reversing multidrug resistance(MDR) of hepatocellul...
[期刊论文] 作者:Jie-yu DAI,Jun-ling YANG,Chuan LI, 来源:中国药理学报(英文版) 年份:2008
Aim:To investigate the limiting factors for oral bioavailability of flavonoids derived from the Chinese herbal remedy Xiaochaihu-tang. The investi-gational flav...
[会议论文] 作者:Peng Chen,Jun-ling Yang,Hui-ying Wu,Xiu-li Wang,Fang Xiao,Zhong-sen Ma, 来源:2014中华医学会呼吸病学年会暨第十五次全国呼吸病学学术会议 年份:2014
[会议论文] 作者:Peng Chen,Jun-ling Yang,Min Ge,Fang Xiao,kkkkli Wang,Zhong-sen Ma, 来源:2014中华医学会呼吸病学年会暨第十五次全国呼吸病学学术会议 年份:2014
[期刊论文] 作者:Chen CHENG,Jia-zhen LIN,Li LI,Jun-ling YANG,Wei-wei JIA,Yu-hong HUANG,Fei-fei DU, 来源:中国药理学报(英文版) 年份:2016
[期刊论文] 作者:Zhe-yi HU,Xiu-xue LI,Fei-fei DU,Jun-ling YANG,Wei NIU,Fang XU,Feng-qing WANG, 来源:中国药理学报(英文版) 年份:2013
[会议论文] 作者:Peng Chen,Jun-ling Yang,Fang Xiao,Bai-hong Zheng,Zhong-sen Ma,Qing-hua Zheng,Zhen Li, 来源:中华医学会呼吸病学年会——2013第十四次全国呼吸病学学术会议 年份:2013
Objective In order to observe the effect of tanreqing combined with antibiotic treatment of pulmonary infection in lung cancer patients.Methods 80 patients were randomly divided into two groups....
[会议论文] 作者:Jian Li,Chen Cheng,Jun-ling Yang,Wei-wei Jia,Olajide E. Olaleye,Ya-ya Wang,Chuan Li, 来源:2017年第三届岭南国际DMPK论坛 年份:2017
[会议论文] 作者:Jian Li,Chen Cheng,Jun-ling Yang,Wei-wei Jia,Olajide E. Olaleye,Ya-ya Wang,Chuan Li, 来源:2017年第三届岭南国际DMPK论坛 年份:2017
Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection....
[期刊论文] 作者:Yun Shi,Si-Ye Wang,Min Yao,Wen-Li Sai,Wei Wu,Jun-Ling Yang,Yin Cai,Wen-Jie Zheng,Deng-Fu Yao,, 来源:World Journal of Gastroenterology 年份:2015
AIM: To investigate small interfering RNA(si RNA)-mediated inhibition of nuclear factor-kappa B(NF-κB) activation and multidrug-resistant(MDR) phenotype format...
[期刊论文] 作者:Olajide E.Olaleye,Wei Niu,Fei-fei Du,Feng-qing Wang,Fang Xu,Salisa Pintusophon,Jun-lan Lu,Jun-ling Yang, 来源:中国药理学报(英文版) 年份:2019
ShenMai,an intravenous injection prepared from steamed Panax ginseng roots (Hongshen) and Ophiopogon japonicus roots (Maidong),is used as an add-on therapy for...
[期刊论文] 作者:Salisa Pintusophon,Wei Niu,Xiao-na Duan,Olajide E Olaleye,Yu-hong Huang,Feng-qing Wang,Yan-fen Li,Jun-ling Yang, 来源:中国药理学报(英文版) 年份:2019
XueShuanTong,a lyophilized extract of Panax notoginseng roots (Sanqi) for intravenous administration,is extensively used as addon therapy in the treatment of is...
[期刊论文] 作者:Wei Wu,Jun-Ling Yang,Yi-Lang Wang,Han Wang,Min Yao,Li Wang,Juan-Juan Gu,Yin Cai,Yun Shi,Deng-Fu Yao,, 来源:World Journal of Hepatology 年份:2016
AIM: To interfere with the activation of nuclear factor-κB(NF-κB) with metformin and explore its effect in reversing multidrug resistance(MDR) of hepatocellul...
[期刊论文] 作者:Min Yao,Deng-Fu Yao,Yin-Zhu Bian,Wei Wu,Xiao-Di Yan,Dan-Dan Yu,Li-Wei Qiu,Jun-Ling Yang,Hai-Jian Zhang, 来源:Hepatobiliary & Pancreatic Diseases International 年份:2013
BACKGROUND: The prognosis of hepatocellular carcinoma (HCC) is poor and its early diagnosis is of the utmost importance. This study aimed to investigate the val...
[期刊论文] 作者:Xin-wei Liu,Jun-ling Yang,Wei Niu,Wei-wei Jia,Olajide E.Olaleye,Qi Wen,Xiao-na Duan,Yü-hong Huang,Feng-qing, 来源:中国药理学报(英文版) 年份:2018
Terpene lactones are a class of bioactive constituents of standardized preparations of Ginkgo biloba leaf extract,extensively used as add-on therapies in patien...
[期刊论文] 作者:Xiao-fang Lan,Olajide E.Olaleye,Jun-lan Lu,Wei Yang,Fei-fei Du,Jun-ling Yang,Chen Cheng,Yan-hong Shi,, 来源:中国药理学报(英文版) 年份:2021
LianhuaQingwen capsule,prepared from an herbal combination,is officially recommended as treatment for COVID-19 in China.Of the serial pharmacokinetic investigations we designed to facilitate identifying LianhuaQingwen compounds that are lik......
[期刊论文] 作者:Chen-chun ZHONG,Feng CHEN,Jun-ling YANG,Wei-wei JIA,Li LI,Chen CHENG,Fei-fei DU,Su-ping ZHANG,Chengying, 来源:中国药理学报(英文版) 年份:2018
Anlotinib is a new oral tyrosine kinase inhibitor; this study was designed to characterize its pharmacokinetics and disposition. Anlotinib was evaluated in rats...
相关搜索: